Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Achaogen Inc AKAOQ

Healthcare Biotechnology
"Achaogen Inc is a biopharmaceutical company developing novel antibacterial treatments against multi-drug resistant gram-negative infections. The company is researching and developing on its product plazomicin used for the treatment of serious bacterial infections. It's another antibacterial candidate, C-Scape treats patients with urinary tract infections. All of the company's revenue is... see more

Recent & Breaking News (OTCPK:AKAOQ)

Achaogen Announces Multiple Plazomicin Presentations at the American Society of Health Systems Pharmacists (ASHP) Midyear Clinical Meeting

GlobeNewswire November 26, 2018

Technological Advancements Show Growth in the Hospital Acquired Infection Control Market

PR Newswire November 16, 2018

36 Stocks Moving In Tuesday's Mid-Day Session

Benzinga.com  November 13, 2018

The Daily Biotech Pulse: Viking's Fatty Liver And Cholesterol Drug, Cyclacel Loss Narrows, Eton's Debut

Benzinga.com  November 13, 2018

Achaogen Announces Presentations at Two Investor Healthcare Conferences in November

GlobeNewswire November 9, 2018

The Daily Biotech Pulse: SITC Presentations Pick Up Pace, Sandoz' Voluntary Recall

Benzinga.com  November 9, 2018

80 Biggest Movers From Yesterday

Benzinga.com  November 9, 2018

Mid-Morning Market Update: Markets Open Lower; Cardinal Health Tops Q1 Views

Benzinga.com  November 8, 2018

The Daily Biotech Pulse: Nantkwest Reports Positive Cancer Vaccine Trial Results, Sarepta Offering

Benzinga.com  November 8, 2018

Achaogen Reports Third Quarter 2018 Financial Results and Provides Corporate Update

GlobeNewswire November 8, 2018

52 Biggest Movers From Yesterday

Benzinga.com  November 6, 2018

Achaogen Announces Review of Strategic Alternatives and Corporate Restructuring

GlobeNewswire November 5, 2018

Achaogen to Host Conference Call and Webcast of Third Quarter 2018 Financial Results on November 8, 2018

GlobeNewswire November 2, 2018

Achaogen Submits Marketing Authorization Application to the European Medicines Agency for Plazomicin

GlobeNewswire October 17, 2018

Achaogen Highlights Multiple Plazomicin Presentations at IDWeek 2018

GlobeNewswire October 3, 2018

Achaogen Announces Multiple Plazomicin Presentations at IDWeek 2018

GlobeNewswire September 19, 2018

The Daily Biotech Pulse: Morphosys Expands Collaboration, Osiris Announces Product Launch, Argenx To Offer Shares

Benzinga.com  September 18, 2018

Achaogen to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference

GlobeNewswire September 18, 2018

Achaogen Highlights Multiple Plazomicin Presentations at ESCMID/ASM 2018 Conference

GlobeNewswire September 4, 2018

Achaogen to Present at the Wedbush PacGrow Healthcare Conference

GlobeNewswire August 13, 2018